Clinical Observation of Recombinant Human Endostatin Combined with CT-guided Percutaneous Micro-wave Ablation in the Treatment of NSCLC Complicated with COPD / 中国药房
China Pharmacy
; (12): 3667-3670, 2017.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-607064
Responsible library:
WPRO
ABSTRACT
OBJECTIVE:
To observe clinical efficacy and safety of recombinant human endostatin(rh-endostatin)com-bined with CT-guided percutaneous microwave ablation in the treatment of non-small cell lung cancer(NSCLC)complicat-ed with chronic obstructive pulmonary disease (COPD).METHODS:
A total of 80 cases of NSCLC complicated with COPD were selected from our hospital during Feb. 2014-Feb. 2016,and then divided into control group and observation group according to random number table,with 40 cases in each group. Control group was treated by CT-guided percutane-ous microwave ablation. Observation group was additionally given rh-endostatin injection 7.5 mg/m2,once a day,d1-14, added into 500 mL 0.9% sodium chloride injection,ivgtt lasting for 4 h,for consecutive 14 d,on the basis of control group;7 d later,next course was performed. A treatment course lasted for 21 d,and they received 4 courses of treat-ment. Survival time,clinical efficacy as well as KPS score and lung function indexes before and after treatment,the oc-currence of ADR were compared between 2 groups.RESULTS:
Median survival time of observation group(19.8 months) was significantly longer than that of control group(15.2 months),and total response rate of observation group(72.5%) was significantly higher than that of control group (55.0%),with statistical significance (P0.05). After treat-ment,KPS score and above lung function indexes levels of 2 groups were increased significantly,and those of observa-tion group were significantly higher than those of control group,with statistical significance (P0.05).CONCLUSIONS:
rh-endostatin combined with CT-guided percutaneous microwave ablation in the treatment of NSCLC complicated with COPD show good clinical efficacy with less ADR,and can significantly improve lung function and quality of life.
Full text:
Available
Database:
WPRIM (Western Pacific)
Aspects:
Patient-preference
Language:
Chinese
Journal:
China Pharmacy
Year:
2017
Document type:
Article